Gonzalez-Angulo et al identified factors predictive of distant metastases in a woman with breast cancer who has had a complete pathologic response to neoadjuvant chemotherapy. This can help identify a patient who may benefit from closer monitoring and more aggressive management. The authors are from the University of Texas M.D. Anderson Cancer Center in Houston.
Patient selection: Woman with breast cancer who has had a complete response following neoadjuvant chemotherapy.
Patient exclusion: Stage IV
Parameters:
(1) clinical extent (clinical stage and/or inflammatory carcinoma)
(2) number of lymph nodes sampled
(3) menopausal status
Parameter |
Finding |
Points |
clinical extent |
inflammatory breast cancer, any stage |
1 |
|
Stage I, II or IIIA and non-inflammatory |
0 |
|
Stages IIIB or IIIC and non-inflammatory |
1 |
number of lymph nodes sampled |
<= 10 |
1 |
|
> 10 |
0 |
menopausal status |
pre-menopausal |
1 |
|
peri- or post-menopausal |
0 |
total number of risk factors =
= SUM(points for all 3 parameters)
Interpretation:
• minimum number of risk factors: 0
• maximum number of risk factors: 3
• The risk of distant metastases increases as the number of risk factors increases.
Number of Risk Factors |
Risk of Distant Metastases at 10 Years |
0 |
3% |
1 |
12% |
2 |
23% |
3 |
69% |
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology